Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | type A flavoprotein, putative | 0.0022 | 0 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0022 | 0 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0057 | 0.2863 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0057 | 0.2863 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0029 | 0.0562 | 0.0151 |
Brugia malayi | FAD binding domain containing protein | 0.0057 | 0.2863 | 0.2863 |
Treponema pallidum | flavodoxin | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0028 | 0.0527 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0057 | 0.2863 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0057 | 0.2863 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0057 | 0.2863 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0035 | 0.1089 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0022 | 0 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0028 | 0.0527 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0057 | 0.2863 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0057 | 0.2863 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0022 | 0 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0035 | 0.1089 | 0.1089 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0057 | 0.2863 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0057 | 0.2863 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0057 | 0.2863 | 1 |
Giardia lamblia | Hypothetical protein | 0.005 | 0.2336 | 0.5 |
Plasmodium vivax | flavodoxin domain containing protein | 0.005 | 0.2336 | 0.8159 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.005 | 0.2336 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0057 | 0.2863 | 1 |
Leishmania major | p450 reductase, putative | 0.0057 | 0.2863 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0057 | 0.2863 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0035 | 0.1089 | 0.1089 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0057 | 0.2863 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0057 | 0.2863 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.005 | 0.2336 | 0.8159 |
Leishmania major | cytochrome P450 reductase, putative | 0.005 | 0.2336 | 0.8159 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.2863 | 0.2863 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0057 | 0.2863 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0057 | 0.2863 | 1 |
Brugia malayi | flavodoxin family protein | 0.0057 | 0.2863 | 0.2863 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0035 | 0.1089 | 0.2407 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0057 | 0.2863 | 0.2863 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0057 | 0.2863 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0057 | 0.2863 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.